Dendritic Cell Cancer Vaccine for High-grade Glioma

Clinical trial NCT01213407 · COMPLETED

Trial details

NCT number: NCT01213407
Sponsor: Activartis Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2010-04-01
Primary completion: 2015-06-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.